Barry Ticho - Dec 1, 2023 Form 4 Insider Report for Stoke Therapeutics, Inc. (STOK)

Role
Chief Medical Officer
Signature
/s/ Stephen Tulipano, Attorney-in-Fact
Stock symbol
STOK
Transactions as of
Dec 1, 2023
Transactions value $
$0
Form type
4
Date filed
12/5/2023, 04:18 PM
Previous filing
Jul 6, 2023
Next filing
Jan 4, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STOK Employee Stock Option (Right to Buy) Disposed to Issuer -60K -100% 0 Dec 1, 2023 Common Stock 60K $20.25 Direct F1, F2
transaction STOK Employee Stock Option (Right to Buy) Disposed to Issuer -65.6K -100% 0 Dec 1, 2023 Common Stock 65.6K $60.00 Direct F3, F4
transaction STOK Employee Stock Option (Right to Buy) Disposed to Issuer -107K -100% 0 Dec 1, 2023 Common Stock 107K $20.34 Direct F5, F6
transaction STOK Restricted Stock Unit (RSU) Award $0 +60.8K $0.00 60.8K Dec 1, 2023 Common Stock 60.8K Direct F7, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The canceled option vested as to 1/48th of the total award on April 25, 2020 and provided for 1/48th of the total award to vest monthly thereafter, subject to the reporting person's continued service to the Issuer through each vesting date.
F2 On December 1, 2023, the Issuer cancelled, pursuant to the Issuer's option exchange program, options to purchase 60,000 shares of Common Stock of the Issuer and in exchange issued to the reporting person 18,749 restricted stock units.
F3 The canceled option vested as to 1/48th of the total award on April 2, 2021 and provided for 1/48th of the total award to vest monthly thereafter, subject to the reporting person's continued service to the Issuer through each vesting date.
F4 On December 1, 2023, the Issuer cancelled, pursuant to the Issuer's option exchange program, options to purchase 65,600 shares of Common Stock of the Issuer and in exchange issued to the reporting person 8,463 restricted stock units.
F5 The canceled option vested as to 1/48th of the total award on April 15, 2022 and provided for 1/48th of the total award to vest monthly thereafter, subject to the reporting person's continued service to the Issuer through each vesting date.
F6 On December 1, 2023, the Issuer cancelled, pursuant to the Issuer's option exchange program, options to purchase 107,400 shares of Common Stock of the Issuer and in exchange issued to the reporting person 33,561 restricted stock units.
F7 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
F8 48,792 restricted stock units will vest on December 1, 2024 and 11,981 will vest on December 1, 2025, subject to the reporting person's continued service to the Issuer on each such date.